Cardiology Clinical Trials

  • Home
  • Cardiology Clinical Trials
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Conditions: Colorectal Carcinoma

Interventions: Other: Best Practice; Other: Communication Intervention; Other: Communication Intervention; Other: Communication Intervention; Other: Interview; Other: Interview

Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 22, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator’s Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Conditions: Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Platinum-resistant Ovarian Cancer
Interventions: Drug: Luveltamab tazevibulin; Drug: Pegfilgrastim; Drug: Gemcitabine; Drug: Paclitaxel; Drug: Pegylated liposomal doxorubicin; Drug: Topotecan
Sponsors: Sutro Biopharma, Inc.; GOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT); Asia-Pacific Gynecologic Oncology Trials Group (APGOT)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 21, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Natural History Study of Kaposi Sarcoma
Conditions: Kaposi Sarcoma; HIV

Sponsors: National Cancer Institute (NCI)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 21, 2024Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Conditions: Multiple Myeloma
Interventions: Biological: Linvoseltamab
Sponsors: Dickran Kazandjian, MD; Regeneron Pharmaceuticals
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Fibrosis Lessens After Metabolic Surgery

Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis (MASH); Liver Fibrosis; Obesity
Interventions: Procedure: Metabolic surgery; Drug: Incretin-Based Therapy
Sponsors: Ali Aminian
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Conditions: Diabetes; Hypertension; High Cholesterol/Hyperlipidemia; Coronary Artery Disease; Congestive Heart Failure; Chronic Lung Disease; Chronic Kidney Diseases; Arrythmia; Stroke; Depression; Anxiety; Pulmonary Embolism; Heart Attack
Interventions: Other: Med AAAction intervention
Sponsors: University of Tennessee; Sponsor GmbH
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management

Conditions: Coronary Artery Disease
Interventions: Diagnostic Test: AI-enabled quantitative coronary plaque analysis (AI-QCPA)
Sponsors: HeartFlow, Inc.
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

Conditions: Type 2 Diabetes
Interventions: Behavioral: Acceptance and Commitment Therapy; Device: Abbott FreeStyle® Libre® 3; Other: Generic Education
Sponsors: Sam Houston State University; Chelsea Ratcliff, Ph.D.; Owen Kelly, Ph.D.,RNutr; Oluwaseun Olaiya, DO; Michael Griffin, Ph.D.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Conditions: Diabetes Mellitus, Type 2; Lifestyle; Hyperglycemia; Physical Inactivity
Interventions: Behavioral: Focused App Prompt; Behavioral: No App Prompt
Sponsors: University of Pittsburgh; Dartmouth College; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Michigan; San Diego State University
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Conditions: Pancreatic Adenocarcinoma; Adenosquamous Carcinoma; Pancreatic Neuroendocrine Tumor; Pancreatic Neuroendocrine Carcinoma; Gastrointestinal Neuroendocrine Tumor; Gastrointestinal Neuroendocrine Carcinoma; Neuroendocrine Prostate Carcinoma
Interventions: Drug: ESK981
Sponsors: University of Michigan Rogel Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 20, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine